Friday, 18 Oct 2019


Date Typesort ascending Title Save
07 Oct 2015 Social The price of generics more than doubled in 1/7 generics. Colchicine price rose 2000% w/ FDA new safety policies.
30 May 2018 Social RT @philipcrobinson: Really interesting ‘Sons of Gout’ study shows asymptomatic crystals present. Is the threshold different?…
22 Oct 2015 Social Gouty arthritis requiring allopurinol is associated with an excess risk of major fractures and hip Fx, moreso in men
27 Nov 2018 Social Despite many excellent therapies, most patients with gout are not adequately managed, and patients and providers have many misconceptions about gout. Great review by Ted Fields, MD
19 Sep 2016 Social DECT imaging studies in gout patients shows that Erosions occur from the outside in (not inside out as in RA).
07 Nov 2017 Social RT @philipcrobinson: Nice data on cumulative incidence of gout by serum urate #ACR17 @RheumNow
16 Jun 2018 Social RT @RheummanArnaldo: @DrPetryna @RheumNow The ACP has not helped with their ridiculous guidelines for management of Gout.
11 Jan 2017 Social FDA reviewing NDA for new combo drug: allopurinol + lesinurad (Ironwood Pharm) to Rx hyperuricemia uncontrolled gout
14 Mar 2019 Social QD44 - RA and Gout via @YouTube
25 Feb 2019 Social QD Clinic - New Changes to Gout Guidelines. Lessons from the clinic - a noncompliant gout patient needs to restart his gout drugs, what to do with febuxostat? via @YouTube
22 Nov 2016 Social CLEAR 2 Lesinurad (Zurampic) 200 or 400 mg added to allopurinol; 55-66% got to SUA <6. But 5-15% renal side effects
08 Nov 2017 Social RT @philipcrobinson: I think that is a simplistic view, skills, knowledge and unknowns probably play a role in my view #ACR17 @RheumNow htt…
29 Apr 2015 Social MRI study of Gout & RA: synovitis in both. Gout had less cartilage damage (CD), but BM edema & CD strongest in RA 
23 Feb 2016 Social Astra-Zeneca's new gout drug, lesinurad (Zurampic) gets EU approval for gout.
19 Apr 2017 Social Acute Arthritis US sensitivity/specificity=double contour 42/92%, IA aggregates 58/92%, tophi 40/100. w/ PPV 88-100%
31 May 2019 Social Korean National Health Insurance data compared the risk of CV events in 39,640 gout pts starting allopurinol or febuxostat. MACE incidence was 1.89 vs 1.84/100PY (HR 1.09; 0.90, 1.32) Thus, no significant difference in CV risk with these agents in Asians
10 Jan 2018 Social Krystexxa annual sales expected to increase from $400 million to $750 million. Horizon reports the number of gout pts treated increased from 50,000 to 100,000.
16 Jun 2015 Social 113 hyperuricemia pts randomized to PBO v allopurinol. Allopurinol had less CKD progression & less CV events(HR 0.43)
20 Aug 2018 Social A study of 27,959 acute coronary syndrome patients shows that the 46% with hyperuricemia (SUA > 6.0) had significantly greaters risks of cardiovascular events, regardless of a diagnosis of gout.
01 May 2016 Social Goofiest study of the month: Pricking blood and moxibustion effective in treating gout in China.